These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9487272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P, Guilhot J, Tilly B, Salanave B, Allemand H.
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.
    Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH.
    Circulation; 2005 Dec 06; 112(23):3569-76. PubMed ID: 16330698
    [Abstract] [Full Text] [Related]

  • 6. An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.
    Stafilas PC, Sarafidis PA, Lasaridis AN, Aletras VH, Niakas DA.
    Am J Hypertens; 2005 Sep 06; 18(9 Pt 1):1233-40; discussion 1241-2. PubMed ID: 16182115
    [Abstract] [Full Text] [Related]

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 06; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 8. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.
    Tang JL, Wang WZ, An JG, Hu YH, Cheng SH, Griffiths S.
    Int J Epidemiol; 2010 Feb 06; 39(1):244-54. PubMed ID: 19491141
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E.
    Can J Cardiol; 2004 Aug 06; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [Abstract] [Full Text] [Related]

  • 15. Toward targeted hypertension screening guidelines.
    van Buuren S, Boshuizen HC, Reijneveld SA.
    Med Decis Making; 2006 Aug 06; 26(2):145-53. PubMed ID: 16525168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation and treatment of severe asymptomatic hypertension.
    Kessler CS, Joudeh Y.
    Am Fam Physician; 2010 Feb 15; 81(4):470-6. PubMed ID: 20148501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.